PCVX
Vaxcyte IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$8.73B
P/E Ratio
—
EPS
$-5.63
Beta
1.39
52W High
$65.00
52W Low
$27.80
50-Day MA
$56.54
200-Day MA
$43.68
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Vaxcyte Inc
Vaxcyte, Inc., a pre-clinical biotech vaccine company, develops novel vaccines to prevent or treat infectious diseases globally. The company is headquartered in Foster City, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-75.00M |
| EBITDA | $-907.28M |
| Operating Margin | 0.00% |
| Return on Equity | -25.60% |
| Return on Assets | -17.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $20.49 |
| Price-to-Book | 3.13 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -14.43 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $143.92M |
| Float | $132.23M |
| % Insiders | 0.58% |
| % Institutions | 104.38% |
Analyst Ratings
Consensus ($109.00 target)
1
Strong Buy9
Buy1
HoldData last updated: 4/9/2026